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Abstract
Urinary tract infection (UTI) is common ailment worldwide with female predominance. 
Catheter associated urinary tract infection (CAUTI) is the most common healthcare 
related infection commonly used in urinary obstruction and incontinence in critically ill 
patients with prolonged indwelling catheterization means more than 30 days, which is 
almost invariable in all patients within 14 days of catheterization which increases mor-
bidity and mortality and treatment expenses. Approximately 80% of nosocomial UTI is 
CAUTI. CAUTI may be asymptomatic and symptomatic. 2–4% cases may develop bacter-
aemia. Organisms responsible for CAUTI is similar to UTI as Escherichia coli the common-
est than proteus, Pseudomonas, Klebsiella, Enterobacter, Enterococci, Candida, Serratia 
and rarely with Delftia tsuruhatensis, Achromobacter xylosoxidans and few others. CAUTI 
can be multibacterial. In CAUTI infective organisms form biofilm and propagate from 
there. E. coli is the most common isolate of CAUTI but Enterobacter cloacae exhibit highest 
biofilm production. CAUTI organisms are more antibiotic resistance than UTI. Even due 
to extensive use of antibiotics now Extended Spectrum Beta Lactamase (ESBL) producing 
CAUTI organisms are isolated from catheter biofilm.
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1. General information about CAUTI
UTI affects approximately 150 million people worldwide, which is most common infection with 
female predominance [1]. Around 15–25% hospitalized patients receiving indwelling urinary 
catheter develops CAUTI with prolonged catheterization and in among 40% nosocomial UTI, 
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80% is due to CAUTI [2]. CAUTI causes about 20% of episodes of health-care acquired bacter-
aemia in intensive care facilities and over 50% in long term care facilities [3]. The microbiology 
of biofilm on an indwelling catheter is dynamic with continuing turnover of organisms in the 
biofilm. Patients continue to acquire new organisms at a rate of about 3–7%/day. In long term 
catheterization that is by the end of 30 days CAUTI develops in 100% patients usually with 2 or 
more symptoms or clinical sign of haematuria, fever, suprapubic or loin pain, visible biofilm in 
character or catheter tube and acute confusion all state [4]. In CAUTI the incidence of infection 
is Escherichia coli in 24%, Candida in 24%, Enterococcus in 14% Pseudomonas in 10%, Klebsiella 
in 10% and remaining part with other organisms [5]. Bacteraemia occurs in 2–4% of CAUTI 
patients where case fatality is three times higher than nonbacteremic patients [6]. Adhesions in 
bacteria initiate attachment by recognizing host cell receptors on surfaces of host cell or cath-
eter. Adhesins initiate adherence by overcoming the electrostatic repulsion observed between 
bacterial cell membranes and surfaces to allow intimate interactions to occur [7]. A biofilm 
is an aggregate of micro-organisms in which cells adhere to each other on a surface embed-
ded within a self-produced matrix of extracellular polymeric substance [8]. In biofilm micro-
organisms growing in colonies within an extra-cellular mucopolysaccharide substance which 
they produce. Tamm-Horsfall protein and magnesium and calcium ions are incorporated into 
this material. Immediately after catheter insertion, biofilm starts to form and organisms adhere 
to a conditioning film of host proteins along the catheter surface. Both the inner and outer 
surfaces of catheter are involved. In CAUTI biofilms are initially formed by one organism but 
in prolonged Catheterization multiple bacteria’s are present. In biofilm main mass is formed by 
extra cellular polymeric substance (EPS) within which organisms live. So there are three layers 
in biofilm, where deeper layer is abiotic, than environmental zone and on surface biotic zone 
[9]. Growth of bacteria in biofilms on the inner surface of catheters promotes encrustation and 
may protect bacteria from antimicrobial agents and the consequence is more drug resistance of 
biofilm organisms. When antibiotic treatment ends the biofilm can again shed bacteria, result-
ing recurrent acute infection. The patients may present as asymptomatic bacteriuria or symp-
tomatic. In symptomatic bacteriuria patient present with fever, suprapubic or costovertebral 
angle tenderness, and systemic symptoms such as altered mentation, hypotension, or evidence 
of a systemic inflammatory response syndrome. In asymptomatic CAUTI diagnosis is made 
with presence of 105 cfu/mL of one bacterial species in a single catheter urine specimen [10]. In 
symptomatic CAUTI bacteriological criteria is present with clinical symptoms.
2. The collection of specimens
It is recommended that urine specimens be obtained through the catheter port using aseptic 
technique or, if a port is not present, puncturing the catheter tubing with a needle and syringe 
in patients with short term catheterization [11]. In long term indwelling catheterization, the 
ideal method of obtaining urine for culture is to replace the catheter and collect the specimen 
from the freshly placed catheter. In a symptomatic patient, this should be done immediately 
prior to initiating antimicrobial therapy. Culture specimens from the urine beg should not be 
obtained [10, 12]. Urine sample can be collected from suprapubic puncture also. Biofilm can 
be cultured from the catheter, for this swab is taken from inner side of catheter.
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3. Microbiologic diagnosis of CAUTI
Catheter Associated Asymptomatic Bacteriuria (CA-ASB) is diagnosed when one or more 
organisms are present at quantitative counts ≥105 cfu/mL from an appropriately collected 
urine specimen in a patient with no symptoms [13]. Lower quantitative counts may be iso-
lated from urine specimens prior to ≥105 cfu/mL being present, but these lower counts likely 
reflect the presence of organisms in biofilm forming along the catheter, rather than bladder 
bacteriuria [14]. Thus, it is recommended that the catheter be removed and a new catheter 
inserted, with specimen collection from the freshly placed catheter, before antimicrobial 
therapy is initiated for symptomatic infection [13]. In biofilm culture, most biofilm contains 
mixed bacterial communities meaning polymicrobial colonization.
Patients who remain catheterized without having antimicrobial therapy and who have 
colony counts ≥10 2 cfu/mL (or even lower colony counts), the level of bacteriuria or candi-
duria uniformly increases to >105 cfu/mL within 24–48 h [14]. Given that colony counts in 
bladder urine as low as 102 cfu/mL are associated with symptomatic UTI in non-catheterized 
patients [15], untreated catheterized patients and those who have colony counts ≥102 cfu/mL 
or even lower, the level of bacteriuria or candiduria uniformly increases to >105 cfu/mL within 
24–48 h [10, 16]. Colony counts as low as 102 cfu/mL in bladder urine may be associated with 
symptomatic UTI in non-catheterized patients. Whereas low colony counts in catheter urine 
specimens are likely to be contaminated by periurethral flora, and the colony counts will 
increase rapidly if untreated. Low colony counts in catheter urine specimens are also reflec-
tive of significant bacteriuria in patients with intermittent catheterization [14].
4. Other laboratory tests
Pyuria is usually present in CA-UTI, as well as in CA-ASB. The sensitivity of pyuria for detect-
ing infections due to enterococci or yeasts appears to be lower than that for gram-negative 
bacilli. Dipstick testing for nitrites and leukocyte esterase was also shown to be unhelpful in 
establishing a diagnosis in catheterized patients hospitalized in the ICU [17].
5. Microorganisms causing CAUTI
5.1. CAUTI with E. coli
5.1.1. Introduction
It is the most common cause of CAUTI in 24–60% patients [5, 18]. In CAUTI the source of this 
organism is usually patients own colonic flora. E. coli is large and diverse group of bacteria 
found in environment, foods and intestine of human and animal. Among many species of 
E. coli only a few causes disease in human being. It is beneficial in that it prevents the 
Microbiology of Catheter Associated Urinary Tract Infection
http://dx.doi.org/10.5772/intechopen.80080
25
growth and proliferation of other harmful species of bacteria. Even it plays an important 
role in current biological engineering.
5.1.2. Structure and pathogenesis
E. coli was discovered in 1885 by Theodor Escherich, German bacteriologist, is gram negative 
rod, lactose fermenter, composed of one circular chromosome which is common facultative 
anaerobes in colon and farces of human. Distribution is diverse and most of them are harmless 
belonging to genus Escherichia. Harmful species causes infection of urinary tract, gastrointes-
tinal tract, respiratory system and rarely bacteraemia and septicemia. Phylogenetic analysis 
of E. coli showed majority of the strains responsible for UTI belongs to the phylogenetic group 
B2 and D, while in smaller percentage belong to A and B1 [19].
It has three antigens O-cell was antigen, H- flagella antigen and k- Capsular antigen. It has pili—a 
capsule, fimbriae, endotoxins and exotoxins also. Uropathogenic E. coli use P fimbriae (pyelone-
phritis-associated pili) to bind urinary tract endothelial cells. Vast majority of catheter-colonizing 
cells (up to 88%) express type 1 fimbriae and around 73% in E. coli causing CAUTI [20]. In UPEC 
fimbrial genes are ygiL, yadN, yfcV, and c2395 [21]. Pathogenesis of CAUTI initiated with UPEC 
colonization in periurethral and vaginal areas. Then it ascends to bladder lumen and grows as 
planktonic cells in urine. Sequentially adherence to bladder epithelium, then biofilm formation 
and invasion with replication and kidney colonization and finally bacteremia [22] (Figure 1).
5.1.3. Laboratory diagnosis
Diagnosis of E. coli infection is simple, by isolation and laboratory identification of bacterium 
from urine or biofilm. Laboratory diagnosis by culture of specimen—urine or catheter biofilm 
in blood agar, MacConkey’s agar or eosin-methylene blue agar (which reveal lactose fermen-
tation). Immunomagnetic separation and specific ELISA, latex agglutination tests, colony 
immunoblot assays, and other immunological-based detection methods are other ways for 
diagnosis of E. coli.
Figure 1. Gram stain picture and morphology of E. coli. Adapted from CCBC faculty web. BIOL 230 Lab Manual: gram 
stain of E. coli and infection landscapes: Escherichia coli. http://faculty.ccbcmd.edu/courses/bio141/labmanua/lab16/
gramstain/gnrod.html.
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5.2. Proteus in CAUTI
5.2.1. Introduction
Proteus species, member of the Enterobacteriaceae family of gram-negative bacilli are distin-
guishable from most other genera by their ability to swarm across an agar surface [23, 24]. 
Proteus species are most widely distributed in environment and as other enterobacteriaceae, 
this bacteria is part of intestinal flora of human being [25, 26]. Proteus also found in multiple 
environmental habitats, including long-term care facilities and hospitals. In hospital setting, it 
is not unusual for proteus species to colonize both the skin and mucosa of hospitalized patient 
and causing opportunistic nosocomial infections. It is one of the common causes of UTI in 
hospitalized patients undergoing urinary catheterization [26, 27].
UTIs are the most common manifestation of Proteus infection. Proteus infection accounts for 1–2% 
of UTIs in healthy women and 5% of hospital acquired UTIs. Catheters associated UTI have a 
prevalence of 20–45%. Proteus mirabilis causes 90% of proteus infection and proteus vulgaris and 
proteus penneri also isolated from long-term care facilities and hospital and from patients with 
underlying disease or specialized care. Most common age group is 20–50 years. More common 
in female group and the ratio between male female begins to decline after 50 years. UTI in men 
younger than 50 are usually caused by urologic abnormalities. Patients with recurrent infections, 
those with structural abnormalities of the urinary tract, those who have had urethral instrumenta-
tion or catheterization have an increase frequency of infection caused by proteus species [28].
5.2.2. Structure and pathogenesis
Proteus mirabilis produces an acidic capsular polysaccharide which was shown from gly-
cose analysis, carboxyl reduction, methylation, periodate oxidation and the application 
high resolution nuclear magnetic resonance techniques. Proteus species possess an extra-
cytoplasmic outer membrane, a common feature shared with other gram-negative bacteria. 
Infection depends upon the interacting organism and the host defense mechanism. Various 
component of the membrane interplay with the host to determine virulence. Virulence 
factors associated with adhesion, motility, biofilm formation, immunoavoidance, nutrient 
acquisition and as well as factors that cause damage to the host [29, 30] (Figure 2).
Certain virulence factors such as adhesin, motility and biofilm formation have been identi-
fied in Proteus species that has a positive correlation with risk of infection. After attachment 
of Proteus with urothelial cells, interleukin 6 and interleukin 8 secreted from the urothelial 
cells causes apoptosis and mucosal endothelial cell desquamation. Urease production of 
proteus also augments the risk of UTI. Urease production, together with the presence of 
bacterial motility and fimbriae or pili, as well as adhesins anchored directly within bacterial 
cell membrane may favor the upper urinary tract infection. Once firmly attached on the 
uroepithelium or catheter surface, bacteria begin to phenotypically change, producing exo-
polysaccharides that entrap and protect bacteria. These attached bacteria replicate and form 
microcolonies that eventually mature into biofilms [31, 32]. Once established, biofilms inher-
ently protect uropathogens from antibiotic and the host immune response [33, 34]. Proteus 
mirabilis as with other uropathogens is capable of adapting to the urinary tract environ-
ment and acquiring nutrients. And this is accomplished by the production of degradative 
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enzymes such urease and proteases, toxins such as Haemolysin Hpm A and iron nutrient 
acquisition proteins.
5.2.3. Laboratory diagnosis
The infection with Proteus can be diagnosed by taking a urine sample for microscopy and 
culture which is sufficient in most of the cases except in few cases where advanced diagnos-
tic tools are used. If the urine is alkaline, it is suggestive of infection with Proteus sp. The 
diagnosis of Proteus is made on swarming motility on media, unable to metabolized lactose 
and has a distinct fishy door. Ultrasound or CT scan to identify renal stone (Struvite stone) 
or to visualized kidneys or surrounding structures. It will allow to exclude other possible 
problems, mimicking symptoms of urinary tract infection [35, 36].
5.3. Pseudomonas in CAUTI
5.3.1. Introduction
Pseudomonas is a gram-negative bacteria belonging to the family Pseudomonadaceae and con-
taining 191 validly described species [37]. Because of their widespread occurrence in water and 
plant seeds, the pseudomonas was observed in early history of microbiology. Pseudomonas is 
flagellated, motile, aerobic organism with Catalase and oxidase-positive. Pseudomonas may be 
the most common nuclear or of ice crystals in clouds, thereby being of utmost importance to the 
formation of snow and rain around the world [38]. All species of Pseudomonas are strict aerobes, 
and a significant number of organisms can produce exopolysaccharides associated with biofilm 
formation [39]. Pseudomonas is an opportunistic human pathogen that is especially adept at 
forming surface associated biofilms. Pseudomonas causes catheter associated urinary tract 
infection(CAUTIs) through biofilm formation on the surface of indwelling catheters, and biofilm 
mediated infection including ventilator associated pneumonia, infections related to mechanical 
heart valves, stents, grafts, sutures, and contract lens associated corneal infection [40].
Figure 2. Gram stain picture and morphology of Proteus. Adapted from CCBC faculty web. BIOL 230 Lab Manual: gram 
stain of Proteus mirabilis and Proteus vulgaris bacteria (SEM) | Macro & Micro: Up Close and Personal | Pinterest | 
Microbiology, Bacteria shapes and Fungi. https://www.pinterest.com › pin.
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Pseudomonas is third ranking causes nosocomial UTI about 12%, where E. coli remain on the 
top [41]. CAUTI is directly associated with duration of catheterization. Within 2–4 days of 
catheterization 15–25% patients develop bacteriuria [42].
5.3.2. Structure and pathogenesis
Pseudomonas aeruginosa is a gram-negative, rod shaped, asporogenous and monoflagellated, 
noncapsular bacterium but many strains have a mucoid slime layer. Pseudomonas has an incred-
ible nutritional versatility. Pseudomonas can catabolize a wide range of organic molecule includ-
ing organic compounds such as benzoate. This, then make Pseudomonas a very ubiquitous 
microorganism and Pseudomonas is the most abundant organism on earth [43] (Figure 3).
Pseudomonas is widely distributed in nature and is commonly present in moist environment 
of hospitals. It is pathogenic only when introduce into areas devoid of normal defense such as 
disruption of mucous membrane and skin, usage of intravenous or urinary catheters and neu-
tropenia due to cancer or in cancer therapy. Its pathogenic activity depends on its antigenic 
structure, enzymes and toxins [44]. Among the enzymes Catalase, Pyocyanin, Proteases, elastase, 
haemolysin, Phospholipase C, exoenzyme S and T and endotoxin and endotoxin A play role in 
disease process and as well as immunosuppression. Pseudomonas can infect almost any organ 
or external site. Pseudomonas in invasive and toxigenic. It attached to and colonized the mucous 
membrane of skin. Pseudomonas can invade locally to produce systemic disease and septicemia. 
Pseudomonal UTs are usually hospital acquired and are associated with catheterization, instru-
mentation and surgery. These infections can involve the urinary tract through an ascending infec-
tion or through bacteriuria spread. These UTIs may be a source of bacteraemia or septicemia [45].
5.3.3. Laboratory diagnosis
Identification of bacterium with microscopy is simple method of identification of pseudo-
monas. Culture and antibiotic sensitivity pattern can be done in most laboratory media 
commonly on blood agar or eosin-methylthionine blue agar. Pseudomonas has inability to 
ferment lactose and has a positive oxidase reaction. Fluorescence under UV light is helpful in 
Figure 3. Gram stain picture and morphology of Pseudomonas aeroginosa. Adapted from Science News. A new 
antibiotic uses sneaky tactics to kill drug-resistant Pseudomonas aeruginosa illustration and Pseudomonas Aeruginosa 
Stock Photos & Pseudomonas Aeruginosa Stock Images—Alams. https://www.alamy.com › stock-photo.
Microbiology of Catheter Associated Urinary Tract Infection
http://dx.doi.org/10.5772/intechopen.80080
29
early identification of colonies. Fluorescence is also used to suggest the presence of pseudo-
monas in wounds [46].
5.4. CAUTI with Klebsiella
5.4.1. Introduction
Urinary catheters are standard medical devices utilized in both hospital and nursing home 
settings are associated with a high frequency of catheter-associated urinary tract infections 
(CAUTI). The contribution of Klebsiella spp. in CAUTI is near about 7.7% [47].
5.4.2. Structure and pathogenesis
Klebsiella pneumoniae is a gram-negative pathogenic bacterium, is part of the Enterobacteriaceae 
family. It has got polysaccharide capsule attached to the bacterial outer membrane, and it fer-
ments lactose. Klebsiella species are found ubiquitously in nature, including in plants, animals, 
and humans. They are the causative agent of several types of infections in humans. It has a large 
accessory genome of plasmids and chromosomal gene loci. This accessory genome divides K. pneu­
moniae strains into opportunistic, hyper virulent, and multidrug-resistant groups [48] (Figure 4).
The source of Klebsiella causing CAUTI can be endogenous typically via meatal, rectal, or 
vaginal colonization or exogenous, such as via equipment or contaminated hands of health-
care personnel. They typically migrate along the outer surface of the indwelling urethral 
catheter, until they enter the urethra.
Migration of the Klebsiella along the inner surface of the indwelling urethral catheter occurs much 
less frequently, compared with along the outer surface Internal (intraluminal) bacterial ascension 
occurs by Klebsiella tend to be introduced when opening the otherwise closed urinary drainage 
system, ascend from the urine collection bag into the bladder via reflux, biofilm formation occurs.
A critical step in progression to CAUTI by Klebsiella is to adhere to host surfaces, which is 
frequently achieved using pili (fimbriae) [49]. Pili are filamentous structures extending from 
Figure 4. Gram stain picture and morphology of Klebsiella pneumonie. Adapted from studyblue.com. Microbio Lab 
Practical I—Microbiology 101 with Johnson at University of Vermont—StudyBlue. Study 368 Microbio Lab Practical I 
flashcards from Tess H. on StudyBlue and Klebsiella Pneumoniae Stock Photos and Pictures. Getty Images https://www.
gettyimages.com › photos.
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the surface of Klebsiella. They can be as long as 10 μm and between 1 and 11 nm in diameter. 
Among the two types of pili—type 1 (fim) pili and type 3 (mrk) pili, type 1 aids virulence by 
their ability to adhere with mucosal surfaces and type 3 pili strongly associated with biofilm 
production [50]. Both fim and mrk pili are considered part of the core genome [51]. It is thought 
that both types of pili play a role in colonization of urinary catheters, leading to CAUTI [52]. 
In addition to fim and mrk pili, a number of additional usher-type pili have been identified 
in Klebsiella with an average of ~8 pili clusters per strain. Based on varying gene frequencies, 
some of these appear to be part of the accessory genome. Immediately after catheterization 
Klebsiella starts biofilm production on the inner as well as outer surface of the catheter and on 
urothelium. Biofilm augments migration of Klebsiella into urethra and urinary bladder. Biofilm 
formation on the catheter surface by Klebsiella pneumoniae causes severe problem. Type 1 and 
type 3 fimbriae expressed by K. pneumoniae enhance biofilm formation on urinary catheters in 
a catheterized bladder model that mirrors the physicochemical conditions present in catheter-
ized patients. These two fimbrial types does not is expressed when cells are grown planktoni-
cally. Interestingly, during biofilm formation on catheters, both fimbrial types are expressed, 
suggesting that they are both important in promoting biofilm formation on catheters [53]. The 
biofilm life cycle illustrated in three steps: initial attachment events with inert surfaces type 1 
and type 3 fimbriae encoded by the mrk ABCDF gene cluster within K. pneumoniae promotes 
biofilm formation [54, 55]. Detachment events by clumps of Klebsiella or by a ‘swarming’ phe-
nomenon within the interior of bacterial clusters, resulting in so-called ‘seeding dispersal’.
Modifiable risk factor are prolonged catheterization, lack of adherence to aseptic catheter 
care, insertion of the indwelling urethral catheter in a location other than an operating room, 
presence of a urethral stent, feecal incontinence. Non-modifiable risk factor—renal disease 
(i.e., serum creatinine >2 mg/dL), diabetes mellitus, older age (i.e., age > 50 years old), female 
sex, malnutrition and severe underlying illness [53]. For infection several virulence factors 
such as surface factors (fimbriae, adhesins, and P and type 1 pili) and extracellular factors 
toxins, siderophores, enzymes, and polysaccharide coatings are necessary for initial adhesion 
with colonization of host mucosal surfaces for tissue invasion overcoming the host defense 
mechanisms, and causing chronic infections [55].
5.4.3. Laboratory diagnosis
Diagnosis of klebsiella infection is by isolation and laboratory identification of bacterium from 
urine or biofilm. Laboratory diagnosis can be done by culture of specimen—urine or catheter 
biofilm in blood agar, MacConkey’s agar. Specific ELISA, latex agglutination tests, PCR and 
other immunological-based detection methods are sophisticated alternatives for diagnosis of 
klebsiella. Determination of a gene on capsule of Klebsiella is rapid and simple method for the 
determination of the K types of most K. pneumoniae clinical isolates [56].
5.5. CAUTI with Enterobacter
5.5.1. Introduction
Enterobacter species, particularly Enterobacter cloacae and Enterobacter aerogenes, are important 
nosocomial pathogens responsible for about 1.9–9% CAUTI, rarely causes bacteremia [57, 58]. 
Enterobacter cloacae exhibited the highest biofilm production (87.5%) among isolated pathogens [53].
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5.5.2. Structure and pathogenesis
Enterobacter bacteria are motile, rod-shaped cells, facultative anaerobic, non-spore-forming, 
some of which are encapsulated belonging to the family Enterobacteriaceae. They are impor-
tant opportunistic and multi-resistant bacterial pathogens. As facultative anaerobes, some 
Enterobacter bacteria ferment both glucose and lactose as a carbon source, presence of orni-
thine decarboxylase (ODC) activity and the lack of urease activity. In biofilms they secrete 
various cytotoxins (enterotoxins, hemolysins, pore-forming toxins. Though it is microflora in 
the intestine of humans, it is pathogens in plants and insects. Amp C β-lactamase production 
by E. cloacae is responsible for cephalosporin resistance. They possess peritrichous, amphitri-
chous, lophotrichous, polar flagella. E. aerogenes flagellar genes and its assembly system have 
been acquired in bloc from the Serratia genus [59] (Figure 5).
5.5.3. Laboratory diagnosis
The most important test to document Enterobacter infections is culture. Direct gram staining 
of the specimen is also useful. In the laboratory, growth of Enterobacter isolates is occurs in 
24 h or less; Enterobacter species grow rapidly on selective (i.e., MacConkey) and nonselective 
(i.e., sheep blood) agars.
5.6. CAUTI with Enterococcus
5.6.1. Introduction
Enterococci are gram-positive facultative anaerobic cocci, two species are common commen-
sal organisms in the intestines of humans: Enterococcus faecalis (90–95%) and Enterococcus 
faecium (5–10%) [60]. Though normally a gut commensal, these organisms are commonly 
responsible for nosocomial infection of urinary tract, biliary tract and blood, particularly 
in intensive care units (ICU) [61]. E. coli is usually the most frequent species isolated from 
Figure 5. Gram stain picture and morphology of Enterobacter species. Adapted from Gram Stain Kit | Microorganism 
Stain | abcam.comAdwww.abcam.com/ and Science Prof Online. Gram-negative Bacteria Images: photos of Escherichia 
coli, Salmonella & Enterobacter and Enterobacter aerogenes | Gram-negative microorganism—HPV Decontamination | 
Hydrogen Peroxide Vapour—Bioquellhealthcare.bioquell.com › microbiology.
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bacteremic catheter associated urinary tract infections (CAUTI). However, Enterococcus spp. 
(28.4%) and Candida spp. (19.7%) were also reported to be most common [62]. In another 
study, E. coli was found the commonest (36%) followed by Enterococcus spp. (25%), Klebsiella 
species (20%) and Pseudomonas spp. (5%) [63].
5.6.2. Structure and pathogenesis
The most important cause of bacteriuria is the formation of biofilm along the catheter surface 
[64]. Enterococcus is gram positive bacteria often found in pairs or short chains. Broadly, 
Enterococcus is in two groups—faecalis and non-faecalis (E. gallinarum and E. casseliflavus). 
Enterococcus faecalis formerly classified as part of the group D Streptococcus is a gram-
positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other 
mammals, survive harsh environmental conditions including drying, high temperatures, and 
exposure to some antiseptics [65]. E. faecalis has the important characteristics of complex set of 
biochemical reactions, including fermentation of carbohydrates, hydrolysis of arginine, toler-
ance to tellurite, and motility and pigmentation. Presence of the catheter itself is essential for 
E. faecalis persistence in the bladder, E. faecalis depends on the catheter implant for persistence 
via an unknown mechanism that more than likely involves its ability to produce biofilms on 
the silicone tubing and immune-suppression [66].
E. faecalis produce a heteropolymeric extracellular hair-like fimbrial structure called the endocar-
ditis- and biofilm-associated pilus-Ebp, having three components the organelle (EbpC), a minor 
subunit that forms the base of the structure (EbpB) and a tip-located adhesin (EbpA) [67]. EbpA 
is responsible for adhesion in urothelial and catheter surface for biofilm production (Figure 6).
5.6.3. Laboratory diagnosis
Urine sample and biofilm microscopy can identify this gram positive organism. Culture 
yields the growth of E. faecalis in appropriate media. Advanced diagnostic methods like 
immunological-based detection methods and PCR are rarely needed for diagnosis.
Figure 6. Morphology of Enterococcus. Adapted from Science Photo Library/Alamy Stock Photo Image ID: F6YBC3.
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5.7. CAUTI with Candida
5.7.1. Introduction
One of the common causes of catheter associated urinary tract infection is fungal infection. 
Bacterial infections are accounted for 70.9% of catheter associated urinary infection. E. coli is 
the most commonly isolated organism (41.6%) whereas fungal infections are accounted for 
16.6% and mixed fungal and bacterial infections accounted for 12.5% [68]. The National noso-
comial infections surveillance (NNIS) data indicated that C. albicans caused 21% of catheter-
associated urinary tract infections, in contrast to 13% of non-catheter-associated infections 
[69]. In one study 24% of the cases showing fungal yeast growth. Candida spp. was the com-
monest. Non-albicans Candida (86%) isolated more commonly than Candida albicans (14%) 
[70]. Candida are commensals, and to be pathogenic, interruption of normal host defenses is 
crucial which is facilitated in conditions like immunocompromised states as AIDS, diabetes 
mellitus, prolonged broad spectrum antibiotic use, indwelling devices, intravenous drug use 
and hyperalimentation fluids [71]. Diabetes mellitus has been reported as the most common 
risk factor for fungal infection [72, 73]. The duration of catheterization is also an important 
risk factor as the duration increases the incidence of fungal infection is increased [74].
5.7.2. Structure and pathogenesis
Candida albicans is an oval, budding yeast, which is a member of the normal flora of mucocutane-
ous membrane. Twenty species of Candida yeasts can cause in human infection but most common 
is Candida albicans. Sometimes it can gain predominance and can produce disease. Other candida 
species that can cause disease occasionally are Candida parapsilosis, Candida tropicalis and Candida 
krusei [75]. Although Candida albicans are common isolates in CAUTI, Candida tropicalis is increas-
ingly reported in CAUTI [76]. The majority of Candida albicans infections are associated with bio-
film formation on host or abiotic surfaces such as indwelling medical devices, which carry high 
morbidity and mortality [63, 77]. Several factors and activities contribute to the pathogenesis of 
this fungus which mediate adhesion to and invasion into host cells, which are in sequences are the 
secretion of hydrolases, the yeast-to-hypha transition, contact sensing and thigmotropism, biofilm 
formation, phenotypic switching and a range of fitness attributes [78] (Figure 7).
Figure 7. Morphology of Candida albicans. Adapted from biomedik8888, Aug 24, 2011. http://www.BioMedik.com.au3.
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5.7.3. Laboratory diagnosis
Urine and materials removed from catheter are needed. Microscopic examinations of gram-
stained specimen showed pseudohyphae and budding cells. Culture on Sabouraud’s agar 
at room temperature and at 37°C showed typical colonies and budding pseudomycelia [79].
5.8. CAUTI with Serratia marcescens
It is facultative anaerobic bacilli gram-negative rod of Enterobacteriaceae family considered 
opportunistic human pathogen but not a component of human facial flora. It is capable of 
producing a pigment called prodigiosin, which ranges in color from dark red to pale pink. It 
is ubiquitously spent in nature and has preference for damp conditions. Though previously 
known as nonpathogenic, but since 1970s it is associated with multi drug resistant infection 
due to presence of R factor—a plasmid. A study in Japan showed 6.8% incidence of UTI with 
this organism [80]. It also causes bacteraemia rarely. Diagnosis is confirmed by culture of the 
urine specimen or catheter biofilm. Automated bacterial identification systems and Matrix-
Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) is 
the other modality for diagnosis of serratia as well as other enterobacteriaceae [81].
5.9. CAUTI with Delftia tsuruhatensis
This non-fermentative gram-negative rod discovered as plant growth-promoting bacterium 
and potential biocontrol agent against plant pathogens. Infection with this uncommon organ-
ism in CAUTI occurs in combination with commonest bacteria E. coli, Klebsiella pneumoniae 
and Pseudomonas aeruginosa. D. tsuruhatensis and E. coli coexist and tend to co-aggregate over 
time and also cooperate synergistically [82]. D. tsuruhatensis metabolized citric acid more 
rapidly leaving more uric acid available in the medium to be used by E. coli for dynamic 
growth of both organisms. Identification of this organism is not confirmatory with culture, so 
molecular methods are more reliable [83].
5.10. CAUTI with Achromobacter xylosoxidans
Achromobacter denitrificans is gram negative bacterium formerly known as Alcaligenes denit­
rificans. Infection with this organism predominantly observed in elderly patients with predis-
posing factors as urological abnormalities, malignancies and immune-suppression. Rarely it 
causes bacteraemia. This bacterium has high level of antibiotic resistance [84].
In polymicrobial biofilm, Achromobacter xylosoxidans cohabits with common organisms 
E. coli, Pseudomonas aeruginosa and Klebsiella pneumoniae. Diagnosis is by bacterial culture 
and molecular methods.
5.11. CAUTI with Staphylococci
Staphylococci (methicillin-sensitive Staphylococcus aureus [MSSA] and methicillin-resistant 
S. aureus [MRSA], Staphylococcus saprophyticus. These are the common gram positive bacteria 
usually responsible for skin and soft tissue infections but rarely cause CAUTI and bacterae-
mia [85].
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The incidence of Staphylococcal UTI as well as CAUTI is increasing and the organisms carry 
wide variety of multidrug-resistant genes on plasmids, which augment spread of resistance 
among other species [86].
Diagnosis is easy, gram stain of the sample, culture is sufficient. Advanced techniques rarely 
needed (Figure 8).
6. Conclusion
CAUTI is one of the most nosocomial Infection worldwide resulting from rational as well 
as sometimes irrational use of indwelling urinary catheter. Cause of CAUTI is formation of 
pathogenic biofilm commonly due to UPEC, Proteus, Klebsiella, Pseudomonas, Enterobacter 
rarely Candida and other uncommon opportunistic organisms. CAUTI has got high impact 
on morbidity and mortality as biofilm producing organisms are more antibiotic resistant. 
Antibiotic resistance is a global problem. Early detection of CAUTI is simple by examination 
of urine and catheter biofilm with microscopy as well as culture with antibiogram. It is easy 
and cost effective with early diagnosis and treatment for good clinical outcome. Advanced 
and sophisticated methods like Immunomagnetic separation, specific ELISA, colony immu-
noblot assays and PCR for diagnosis of CAUTI is seldom necessary.
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Figure 8. Morphology of Staphylococcus aureus. Adapted from abcam.comAdwww.abcam.com/ pharmacist-driven 
intervention improves care of patients with S aureus Bacteremia/Staph aureus. Nebraska Medicine https://asap.
nebraskamed.com.
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